Cases & Deals

Baxalta merges with Shire in $32 billion biotechnology deal

Clients Baxalta Incorporated

Jones Day represented Baxalta Incorporated, a biopharmaceutical manufacturer headquartered in Northern Illinois, as global antitrust and competition law counsel in its $32 billion merger with Ireland based Shire plc to create a leading biotechnology company focused on treatments for rare diseases.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.